Paediatrics
Paediatrics

Comparison of open and closed reduction and percutaneous pinning for pediatric lateral humeral condyle fractures: A systematic review and meta-analysis

Medicine (Baltimore). 2025 Apr 11;104(15):e42060. doi: 10.1097/MD.0000000000042060. ABSTRACT BACKGROUND: Open reduction and percutaneous pinning (ORPP) is commonly regarded as the primary treatment option for serious …

Public knowledge of food poisoning, risk perception and food safety practices in Saudi Arabia: A cross-sectional survey following foodborne botulism outbreak

Medicine (Baltimore). 2025 Apr 11;104(15):e41593. doi: 10.1097/MD.0000000000041593. ABSTRACT To investigate food poisoning knowledge, risk perception and safe food handling practices among Saudi Arabian public following …

Perioperative and Mid-Term Oncological and Functional Outcomes After Partial Nephrectomy for Entirely Endophytic Renal Tumors: A Prospective Multicenter Observational Study (The RECORD2 Project)

Cancers (Basel). 2025 Apr 5;17(7):1236. doi: 10.3390/cancers17071236. ABSTRACT BACKGROUND AND OBJECTIVES: Totally endophytic renal tumors are a unique subset that pose significant technical challenges during …

Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond Treatment

Cancers (Basel). 2025 Apr 6;17(7):1238. doi: 10.3390/cancers17071238. ABSTRACT Background/Objectives: Parents of children with acute lymphoblastic leukaemia (ALL) experience emotional distress throughout their child’s treatment course. …

Leveraging the Patient and Family Voice in the Development of Patient Education: Supporting the Pediatric Oncology Experience

Cancers (Basel). 2025 Apr 1;17(7):1201. doi: 10.3390/cancers17071201. ABSTRACT Given the understandable patient and caregiver distress that often fluctuates across treatment, especially at diagnosis and with …

Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome Profiling

Cancers (Basel). 2025 Apr 6;17(7):1239. doi: 10.3390/cancers17071239. ABSTRACT BACKGROUND/OBJECTIVES: Prostate-specific membrane antigen (PSMA) is a well-established target in prostate cancer therapy that has shown potential …